Biomarin Pharmaceutical Inc (BMRN) Insider Trading

Total insider buys:
  • $1,316,196.75
Total insider sells:
  • $342,139,664.94
Most recent insider trade:
  • Nov. 12, 2024
Most active insider trader:
  • Jean Jacques Bienaime
Trader NameDateTitleAmountPriceTypeTotal Value
Sept. 28, 2017EVP18,415$92.43Sell$1,702,098.45
Sept. 22, 2017EVP3,521$95.00Sell$334,495.00
Sept. 15, 2017Insider15,000$90.50Sell$1,357,500.00
Sept. 15, 2017Director3,750$91.26Sell$342,225.00
June 23, 2017EVP9,844$96.60Sell$950,930.40
June 22, 2017SVP2,671$100.00Sell$267,100.00
June 19, 2017Insider15,000$90.00Sell$1,350,000.00
June 16, 2017Director3,750$90.00Sell$337,500.00
June 7, 2017EVP1,004$89.61Sell$89,968.44
June 5, 2017EVP9,471$91.04Sell$862,239.84
June 5, 2017CEO10,000$90.13Sell$901,300.00
May 24, 2017CEO5,000$88.38Sell$441,900.00
May 17, 2017CEO5,000$91.73Sell$458,650.00
May 8, 2017SVP7,482$91.87Sell$687,371.34
May 8, 2017CEO10,000$96.09Sell$960,900.00
May 5, 2017EVP2,500$100.34Sell$250,850.00
May 2, 2017EVP302$96.74Sell$29,215.48
April 27, 2017CEO5,000$95.72Sell$478,600.00
April 25, 2017CEO5,000$94.00Sell$470,000.00
March 29, 2017EVP3,890$89.15Sell$346,793.50
March 16, 2017EVP2,238$91.96Sell$205,806.48
March 16, 2017CFO1,989$91.96Sell$182,908.44
March 16, 2017CEO10,000$91.69Sell$916,900.00
March 10, 2017CEO11,000$90.59Sell$996,490.00
March 7, 2017EVP5,000$90.56Sell$452,800.00
March 6, 2017EVP1,498$93.32Sell$139,793.36
March 6, 2017CFO2,303$93.32Sell$214,915.96
March 1, 2017CFO35,000$94.07Sell$3,292,450.00
March 1, 2017Director7,500$95.00Sell$712,500.00
Feb. 24, 2017Insider15,000$87.99Sell$1,319,850.00
Jan. 26, 2017CEO10,000$84.22Sell$842,200.00
Jan. 11, 2017CEO8,000$90.58Sell$724,640.00
Jan. 9, 2017CEO8,000$88.49Sell$707,920.00
Jan. 9, 2017CFO5,000$90.00Sell$450,000.00
Dec. 30, 2016CEO8,000$83.60Sell$668,800.00
Nov. 22, 2016CEO69,743$85.69Sell$5,976,277.67
Nov. 21, 2016CEO69,744$87.56Sell$6,106,784.64
Nov. 8, 2016CEO140,000$82.67Sell$11,573,800.00
Nov. 7, 2016CEO70,000$82.52Sell$5,776,400.00
Oct. 28, 2016CEO120,000$81.30Sell$9,756,000.00
Oct. 17, 2016CEO41,666$84.39Sell$3,516,193.74
Oct. 14, 2016CEO64,125$86.96Sell$5,576,310.00
Sept. 29, 2016CEO53,125$93.65Sell$4,975,156.25
Sept. 27, 2016EVP18,467$95.61Sell$1,765,629.87
Sept. 16, 2016CEO137,368$95.34Sell$13,096,665.12
Aug. 26, 2016EVP15,000$95.06Sell$1,425,900.00
Aug. 16, 2016CEO41,666$91.49Sell$3,812,022.34
Aug. 1, 2016VP287$100.00Sell$28,700.00
Aug. 1, 2016CFO4,000$99.33Sell$397,320.00
Aug. 1, 2016EVP2,167$100.00Sell$216,700.00
  • Insiders are both buying and selling Biomarin Pharmaceutical Inc stock.

  • The insider traders at Biomarin Pharmaceutical Inc are: Jean Jacques Bienaime, Jeffrey Robert Ajer, George Eric Davis, Henry J Fuchs, Daniel K Spiegelman, V Bryan Lawlis, Brian Mueller, Robert Baffi, Henry Fuchs, Mark Wood, Richard A Meier, Michael G Grey, Alan Lewis, Charles Greg Guyer, Elaine J Heron, Henry J. Fuchs, Mark J Alles, Erin Burkhart, Dennis Slamon, Mueller Brian, Davis George Eric, David E I Pyott, Daniel K. Spiegelman, and Willard H Dere

  • The most active insider trader at Biomarin Pharmaceutical Inc is Jean Jacques Bienaime with 153 trades.

  • Jean Jacques Bienaime has sold the most Biomarin Pharmaceutical Inc stock with a total value of $179,727,061.76.

  • David E I Pyott has bought the most Biomarin Pharmaceutical Inc stock with a total value of $2,003,456.00.

  • The most recent insider trade for Biomarin Pharmaceutical Inc was on Nov. 12, 2024.

  • The single biggest insider buy for Biomarin Pharmaceutical Inc was from David E I Pyott with a total value of $1,001,728.00 on Aug. 31, 2020.

  • The single biggest insider sell for Biomarin Pharmaceutical Inc was from Henry J Fuchs with a total value of $16,430,570.00 on July 20, 2020.